← SynDRA
TG-101209
SynDRA canonical compound SYN0086592 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | JAK3 |
|---|
| Mechanism of action | JAK inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
Cross-references
Synonyms
- TG101209
- CHEBI:90304
- RefChem:188985
- TG 101209
- MFCD15528085
- C26H35N7O2S
- 1M3
- Kinome_702
- MLS006011064
- SCHEMBL265061
- orb1304575
- SCHEMBL29432552
- BDBM192755
- GLXC-90158
- HMS3656B15
- EX-A1753
- s2692
- AKOS005259288
- CCG-203019
- CS-0476
- EX-8667
- SB19294
- SDCCGSBI-0654431.P001
- NCGC00262608-02
- NCGC00262608-05
- NCGC00262608-09
- NCGC00262608-11
- AC-26864
- AS-16247
- HY-10410
- SMR004702856
- DB-079622
- TG101209?
- SW219632-1
- T3065
- BRD-K39841531-001-02-1
- N-(1,1-Dimethylethyl)-3-[[5-methyl-2-[[4-(4-methyl-1-piperazinyl)phenyl]amino]-4-pyrimidinyl]amino]benzenesulfonamide
Look up TG-101209 in the interactive SynDRA portal →